ModelEdge

ReShape LifeSciences Inc.
RSLS
Filing Type8-K
Filing Date8/18/2025
Updated8/19/25, 3:29 PM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EIGHTH AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY
EX-3.2NINTH AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY
EX-3.3AMENDED AND RESTATED CERTIFICATE OF DESIGNATION TO SERIES C CONVERTIBLE PREFERRED STOCK
EX-3.4CERTIFICATE OF MERGER MERGING RAIDER LIFESCIENCES INTO VYOME THERAPEUTICS, INC
EX-10.1INTERIM FULL-TIME CHIEF FINANCIAL OFFICER CONSULTING AGREEMENT
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic